EMMA — Emmaus Life Sciences, Inc.
Price · —
0 daily closes shownNot enough price history to draw a chart.
Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-07-14.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2024-09-16 | Lim Seah H. Director | Open-market purchase | 20.0K | 0.04 | 800 |
| 2024-02-29 | LEE WILLIS C Co-President & COO | Open-market purchase | 77.0K | 0.13 | 10.0K |
| 2024-02-28 | LEE WILLIS C Co-President & COO | Open-market purchase | 15.0K | 0.12 | 1.8K |
| 2024-02-27 | LEE WILLIS C Co-President & COO | Open-market purchase | 10.0K | 0.13 | 1.3K |
| 2024-02-26 | LEE WILLIS C Co-President & COO | Open-market purchase | 13.2K | 0.12 | 1.6K |
| 2023-12-20 | Lim Seah H. Director | Open-market sale | 32.5K | 0.05 | 1.6K |
| 2023-12-15 | Lim Seah H. Director | Other Acquisition/Disposition | 4.4M | 0.29 | 1.3M |
| 2023-12-15 | ZEN Wei Peu Director | Other Acquisition/Disposition | 3.8M | 0.29 | 1.1M |
| 2023-12-15 | Lim Seah H. Director | Open-market sale | 6.0K | 0.11 | 660 |
| 2023-11-30 | LEE WILLIS C COO | Open-market purchase | 59.4K | 0.12 | 7.1K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-05-15 | 2026-05-15 | on EDGAR ↗ |
| 10-Q | 2026-05-15 | 2026-03-31 | on EDGAR ↗ |
| 3 | 2026-04-21 | 2026-04-16 | on EDGAR ↗ |
| 8-K | 2026-04-17 | 2026-04-16 | on EDGAR ↗ |
| 8-K | 2026-04-14 | 2026-04-13 | on EDGAR ↗ |
| 8-K | 2026-03-31 | 2026-03-30 | on EDGAR ↗ |
Recent headlines
- Emmaus Life Sciences, Inc. (EMMA) filed form 8-K · 2026-08-14 · SEC EDGAR
- Emmaus Life Sciences, Inc. (EMMA) filed form 8-K · 2026-08-14 · SEC EDGAR
- Emmaus Life Sciences, Inc. (EMMA) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about EMMA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →